Filing metadata

Accession number
0001610717-23-000285
Form type
Form 4
Filer
Neumora Therapeutics, Inc.
CIK
CIK 1885522
Filed
Sep 18, 2023
Reporting period
Sep 14, 2023
Description
Insider transaction

Explore SEC Filings Hub